From the Guidelines
Trazodone is not recommended for insomnia in patients with central sleep apnea due to its potential to worsen the condition. Central sleep apnea is a condition where breathing repeatedly stops during sleep due to the brain not sending proper signals to the breathing muscles, and trazodone may potentially exacerbate this condition by affecting serotonin levels and having respiratory depressant effects that could worsen breathing problems during sleep 1.
Key Considerations
- The American Academy of Sleep Medicine clinical practice guideline suggests that clinicians not use trazodone as a treatment for sleep onset or sleep maintenance insomnia in adults 2.
- A systematic review reported no differences in sleep efficiency or rate of discontinuation due to adverse events between trazodone and placebo in patients diagnosed with chronic insomnia, but the review had several limitations, including studies of very short durations of therapy and follow-up of only 1 to 4 weeks 1.
- The work group advised against use of benzodiazepines or trazodone for treatment of chronic insomnia disorder due to the widely known harms and adverse effects of these medications, including risk for dependency and diversion, falls and cognitive impairment in older patients, hypoventilation in patients with respiratory conditions, and neuromuscular diseases 1.
Alternative Approaches
- For patients with central sleep apnea, first-line treatments should focus on addressing the underlying cause of the sleep apnea, which might include positive airway pressure therapy, supplemental oxygen, or treatment of heart failure if present.
- Non-pharmacological approaches such as cognitive behavioral therapy for insomnia (CBT-I), maintaining regular sleep schedules, and creating a sleep-conducive environment should be prioritized before considering any sedative medications in these patients 3.
- If medication for insomnia is necessary, consultation with a sleep specialist is recommended to determine appropriate options.
From the Research
Trazodone for Insomnia in Central Sleep Apnea
- There is limited research on the use of trazodone for insomnia in patients with central sleep apnea.
- A study on the effects of trazodone on insomnia with short sleep duration phenotype found that trazodone significantly improved objective sleep duration and reduced hypothalamic-pituitary-adrenal axis activation 4.
- However, this study did not specifically address central sleep apnea.
- A review of central sleep apnea discussed various treatment options, including positive pressure therapy, adaptive-servo ventilation, supplemental oxygen, phrenic nerve stimulation, and pharmacologic therapy, but did not mention trazodone 5.
- Other studies focused on cognitive behavioral therapy for insomnia in patients with comorbid insomnia and obstructive sleep apnea, which may not be directly applicable to central sleep apnea 6, 7, 8.
- Therefore, there is currently no direct evidence to support the use of trazodone for insomnia in patients with central sleep apnea.
Considerations for Treatment
- Central sleep apnea is a complex condition that requires careful management, and treatment should be individualized based on the underlying cause and severity of the condition.
- Patients with central sleep apnea should be evaluated and treated by a healthcare professional with expertise in sleep medicine.
- Further research is needed to determine the safety and efficacy of trazodone for insomnia in patients with central sleep apnea.